Microdialysis assessment of 5-fluorouracil release from thermosensitive magnetoliposomes induced by an electromagnetic field in tumor-bearing mice

Journal of Drug Targeting

Volumn 5, Issue 5, 1998, Pages 379-390

  Viroonchatapan, Ekapop ^a   Sato, Hitoshi ^a   Ueno, Masaharu ^a   Adachi, Isao ^a   Murata, Jun ^a   Saiki, Ikuo ^a   Tazawa, Kenji ^a   Horikoshi, Isamu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

5 fluorouracil; Dextran magnetite; Drug release; Electromagnetic induction heating; Melanoma; Microdialysis; Thermosensitive magnetoliposomes

Indexed keywords

DEXTRAN MAGNETITE; FLUOROURACIL; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG RELEASE; DRUG TUMOR LEVEL; ELECTROMAGNETIC FIELD; EVAPORATION; FEMALE; HEAT SENSITIVITY; HEATING; INTRATUMORAL DRUG ADMINISTRATION; MELANOMA; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031709842     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869808997865     Document Type: Article

References (35)

1. Anada H., Nakamura N. and Marunio H. (1974) Studies on the metabolic fate of 5-fluorouracil in the oral administration. Yakugaku Zasshi, 94, 1131-1138.
2. Bartlett G.R. (1959) Phosphorus assay in column chromatography. J. Biol. Chem., 234, 466-468.
3. Borrelli N.F., Luderer A.A. and Panzarino J.N. (1984) Hysteresis heating for the treatment of tumours. Phys. Med. Biol., 29, 487-494.
4. De Cuyper M. and Joniau M. (1988) Magnetoliposomes: formation and structural characterization. Ear. Biophys. J., 15, 311-319.
5. Hassan E.E. and Gallo J.M. (1993) Targeting anticancer drugs to the brain. I: enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J. Drug Targeting, 1, 7-14.
6. Huang S.K., Stauffer P.R., Hong K., Guo J.W.H., Phillips T.L., Huang A. and Papahadjopoulos D. (1994) Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res., 54, 2186-2191.
7. Ibrahim A., Couvreur P., Roland M. and Speiser P. (1983) New magnetic drug carrier. J. Pharm. Pharmacol., 35, 59-61.
8. Ishii F., Takamura A. and Ishigami Y. (1990) Preparation and characterization of lipid vesicles containing magnetite and an anticancer drug. J. Dispersion Sci. Technol., 11, 581-592.
9. Jordan A., Wust P., Fähling H., John W., Hinz A. and Felix R. (1993) Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia, 9, 51-68.
10. Kitazawa H., Sato H., Adachi I., Masuko Y. and Horikoshi I. (1997) Microdialysis assessment of fibrin glue containing sodium alginate for local delivery of doxorubicin in tumor- bearing rats. Biol. Pharm. Bull., 20, 278-281.
11. Kitazawa H., Sato H., Adachi I. and Horikoshi I. (1997) Microdialysis assessment of microfibrous collagen containing sodium alginate for local delivery of amikacin. Yakuzaigaku, 56, 232-238.
12. Kiwada H., Sato J., Yamada S. and Kato Y. (1986) Feasibility of magnetic liposomes as a targeting device for drugs. Chem. Pharm. Bull., 34, 4253-4258.
13. Luderer A.A., Borrelli N.F., Panzarino J.N., Mansfield G.R., Hess D.M., Brown J.L., Barnett E.H. and Hahn E.W. (1983) Glassceramic-mediated, magnetic-field-induced localized hyperthermia: response of a murine mammary carcinoma. Radiat. Res., 94, 190-198.
14. Maruyama K., Unezaki S., Takahashi N. and Iwatsuru M. (1993) Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta., 1149, 209-216.
15. Masuko Y., Tazawa K., Sato H., Viroonchatapan E., Takemori S., Shimizu T., Ohkami H., Nagae H., Fujimaki M., Horikoshi I. and Weinstein J.N. (1997) Antitumor activity for selective hyperthermia in tumor hearing rats using thermosensitive magnetoliposomes as a new hyperthermic material. Drug Delivery, 4, 37-42.
16. Nishimura Y., Ono K., Hiraoka M., Masunaga S., Jo S., Shibamoto Y., Sasai K., Abc M., Iga K. and Ogawa Y. (1990) Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat. Res., 122, 161-167.
17. Park J-G., Kramer B.S., Steinberg S.M., Carmichael J., Collins J.M., Minna J.D. and Gazdar A.F. (1987) Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res., 47, 5875-5879.
18. Petru E., Sevin B.U., Perras J., Boike G., Ramos R., Nguyen H. and Averette H.E. (1990) Comparative Chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence. Gynecol Oncol., 38, 155-160.
19. Sato H., Kitazawa H., Adachi I. and Horikoshi I. (1996) Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor. cyclosporin A, for local delivery of etoposide. Pharm. Res., 13, 1563-1567.
20. Tacker J.R. and Anderson R.U. (1982) Delivery of antitumor drug to bladder cancer by use of phase transition liposomes and hyperthermia. J. Urol. 127, 1211-1214.
21. Takemori S., Tazawa K., Nagae H., Yamashita I., Kato H., Okamoto M., Saito M., Kasagi T., Maeda M., Honda T. and Fujimaki M. (1991a) A study of inductive heating for cancer with use of dextran magnetite (I): characteristics of dextran magnetite. Jpn. J. Hyperthermic Oncol., 7, 373-380.
22. Takemori S., Tazawa K., Nagae H., Yamashita I., Kato H., Kasagi T., Maeda M., Honda T. and Fujimaki M. (1991b) A study of DDS in hyperthermia: inductive heating with use of dextran magnetite (DM). Drug Deliver Syst., 6, 465-470.
23. Takemori S., Tazawa K., Nagae H., Shimizu T., Masuko Y., Okamoto M. and Fujimaki M. (1992) Hyperthermia for cancer with dextran magnetite using tubular implants. Jpn. J. Cancer Chemother., 19, 1648-1650.
24. Tazawa K., Nagae H., Takemori S., Yamashita I., Kato H., Okamoto M., Saito M., Kasagi T., Maeda M., Honda T. and Fujimaki M. (1991) A study of inductive heating for cancer with use of dextran magnetite (II): effect for various cancer cells by intracellular hyperthermia. Jpn. J. Hyperthermic Oncol., 7, 381-390.
25. Terashima M., Hayashi K., Fukushima M., Ide H., Iizuka T., Kakegawa T., Ando N., Tanaka O., Shinoda M., Isono K., Ishida K., Ikeuchi S., Endo M., Takiyama W. and Yanagawa T. (1996) Drug sensitivity testing for clinical samples from oesophageal cancer using adhesive tumour cell culture system. Br. J. Cancer., 74, 73-77.
26. Trotter G.A., Morgan G.R., Goeting N., Cooper A.J. and Taylor I. (1984) Prognostic factors and in vitro cytotoxic sensitivity in colorectal cancer. Br. J. Surg., 71, 944-946.
27. Ueno M., Zou Y., Yamagishi M. and Horikoshi I. (1989) Basic study on hepatic artery chemoembolization and tumor selective drug targeting by temperature-sensitive liposome with local hyperthermia. Jpn. J. Cancer Chemother., 16, 3735-3738.
28. Viroonchatapan E., Ueno M., Sato H., Adachi I., Nagae H., Tazawa K. and Horikoshi I. (1995) Preparation and characterization of dextran magnetite-incorporated thermosensitive liposomes: an on-line flow system for quantifying magnetic responsiveness. Pharm. Res., 12, 1176-1183.
29. Viroonchatapan E., Sato H., Ueno M., Adachi I., Tazawa K. and Horikoshi I. (1996) Magnetic targeting of thermosensitive magnetoliposomes to mouse livers in an in situ on-line perfusion system. Life Sci., 58, 2251-2261.
30. Viroonchatapan E., Sato H., Ueno M., Adachi I., Tazawa K. and Horikoshi I. (1997) Release of 5-fluorouracil from thermosensitive magnetoliposomes induced by an electromagnetic field. J. Controlled Release, 46, 263-271.
31. Weinstein J.N., Magin R.L., Yatvin M.B. and Zaharko D.S. (1979) Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science, 204, 188-191.
32. Weinstein J.N., Magin R.L., Cysyk R.L. and Zaharko D.S. (1980) Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate. Cancer Res., 40, 1388-1395.
33. Yatvin M.B., Mühlensiepen H., Porschen W., Weinstein J.N. and Feinendegen L.E. (1981) Selective delivery of liposome- associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth. Cancer Res., 41, 1602-1607.
34. Zou Y., Horikoshi I., Ueno M., Gu X. and Perez-Soler R. (1992) Targeting liver tumors by administering liposomal doxorubicin into the hepatic artery. Int. J. Cancer, 51, 232-237.
35. Zou Y., Yamagishi M., Horikoshi I., Ueno M., Gu X. and Perez- Soler R. (1993) Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Cancer Res., 53, 3046-3051.